Skip to content
CNS Clinical Research

Rochester, Minnesota

CNS clinical trials in Rochester, MN

39 CNS studies are recruiting participants at sites in Rochester as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Rochester at a glance

  • 39 studies are recruiting at a site in Rochester.
  • By phase: Early Phase 1 (1), Phase 1 (1), Phase 1/2 (3), Phase 2 (3), Phase 3 (6), Phase 4 (3), No phase (14), Observational (8). Studies of devices and behavioral approaches have no phase.
  • By sponsor: university, hospital or other (25), industry (13), government (1).
  • By research area: Epilepsy (14), Depression (10), Multiple Sclerosis (5), Parkinson's Disease (5), Migraine (3), ADHD (1), Schizophrenia (1).
  • Most recent update to one of these records: November 16, 2026.

Depression studies recruiting in Rochester

Basic details from each study's public record (the 30 most recently updated of 39). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. E-Mindfulness Approaches for Living After Breast Cancer

    • Phase 3
    • Ages 18 to 50
    • All sexes
    Sponsor
    NRG Oncology
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT06748222 · updated
  2. A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Mayo Clinic
    Registry record
    NCT07227454 · updated
  3. EEG-Guided Transcranial Magnetic Stimulation for Adults With Depression

    • No phase
    • Ages 22 to 60
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic
    Registry record
    NCT07862205 · updated
  4. Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

    • No phase
    • Ages 22 to 70
    • All sexes
    Sponsor
    Abbott Medical Devices
    Study site
    Mayo Clinic
    Registry record
    NCT06423430 · updated
  5. Intravenous Ketamine for Treatment-Resistant Depression

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT06668571 · updated
  6. Effect of Vagal Nerve Stimulation on Gastric Motor Functions

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT06038929 · updated
  7. Ketogenic Intervention for Bipolar Depression

    • No phase
    • Ages 18 to 50
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT07121894 · updated
  8. RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)

    • Phase 4
    • Ages 18 to 65
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT07266545 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Rochester, MN on ClinicalTrials.gov.

ADHD studies recruiting in Rochester

  1. The Myelin Disorders Biorepository Project

    • Observational
    • All ages
    • All sexes
    Sponsor
    Children's Hospital of Philadelphia
    Study site
    Mayo Clinic
    Registry record
    NCT03047369 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Rochester, MN on ClinicalTrials.gov.

Parkinson's disease studies recruiting in Rochester

  1. DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    AstraZeneca
    Registry record
    NCT06989112 · updated
  2. Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Mayo Clinic - Rochester ( Site 0148)
    Registry record
    NCT06170788 · updated
  3. Intraoperative Microelectrode Recordings Using MAVEN Compared to Standard Recording Apparatuses

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic
    Registry record
    NCT07868614 · updated
  4. GBPDC: Gut-Brain in PD Consortium Master Protocol

    • Observational
    • Ages 21 to 80
    • All sexes
    Sponsor
    Duke University
    Study site
    Mayo Clinic
    Registry record
    NCT07567794 · updated
  5. Natural History Study of Synucleinopathies

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    NYU Langone Health
    Study site
    Mayo Clinic
    Registry record
    NCT01799915 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Rochester, MN on ClinicalTrials.gov.

Multiple sclerosis (MS) studies recruiting in Rochester

  1. Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

    • Phase 3
    • Ages 18 to 55
    • All sexes
    Sponsor
    National Institute of Allergy and Infectious Diseases (NIAID)
    Study site
    Mayo Clinic
    Registry record
    NCT04047628 · updated
  2. Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

    • Phase 1/2
    • Ages 18 to 65
    • All sexes
    Sponsor
    Tr1X, Inc.
    Study site
    Mayo Clinic
    Registry record
    NCT07477639 · updated
  3. Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

    • No phase
    • Ages 18 to 85
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT06788886 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Rochester, MN on ClinicalTrials.gov.

Epilepsy studies recruiting in Rochester

  1. Biomarker Targeted Stimulation for Epileptiform Events

    • No phase
    • Ages 7 and older
    • Male participants
    Sponsor
    Cadence Neuroscience
    Study site
    Mayo Clinic
    Registry record
    NCT06424977 · updated
  2. Genetic Markers of Cardiovascular Disease in Epilepsy

    • Observational
    • Ages 18 to 50
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic
    Registry record
    NCT02824822 · updated
  3. ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

    • Phase 1/2
    • Ages 2 to 12
    • All sexes
    Sponsor
    Ionis Pharmaceuticals, Inc.
    Study site
    Mayo Clinic
    Registry record
    NCT07531745 · updated
  4. Optimizing Brain Stimulation Parameters

    • No phase
    • Ages 6 and older
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic Rochester
    Registry record
    NCT06617845 · updated
  5. Diagnosing Epilepsy To EffeCT Change

    • No phase
    • Ages 18 to 75
    • All sexes
    Sponsor
    Epiminder America, Inc.
    Study site
    Mayo Clinic - Rochester
    Registry record
    NCT07110337 · updated
  6. A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

    • Phase 1/2
    • From 6 months, up to 17 years
    • All sexes
    Sponsor
    Encoded Therapeutics
    Study site
    Mayo Clinic
    Registry record
    NCT05419492 · updated
  7. Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

    • Observational
    • Ages 18 to 75
    • All sexes
    Sponsor
    Epiminder America, Inc.
    Study site
    Mayo Clinic - Rochester
    Registry record
    NCT07110454 · updated
  8. Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables

    • Early Phase 1
    • Ages 18 to 75
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT07012148 · updated
  9. Subcortical Arousal in Perceptual Awareness

    • No phase
    • Ages 13 and older
    • All sexes
    Sponsor
    Yale University
    Study site
    Mayo Clinic
    Registry record
    NCT06934356 · updated
  10. Thalamus Seizure Detection With a Deep Brain Stimulator System

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT06700356 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Rochester, MN on ClinicalTrials.gov.

Migraine studies recruiting in Rochester

  1. Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

    • Phase 4
    • Ages 18 to 70
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic
    Registry record
    NCT06972056 · updated
  2. Randomized Study in Children and Adolescents With Migraine: Acute Treatment

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study sites
    Brackenridge Outpatient Research Pharmacy · Clinical Research Trials Unit · Mayo Clinic
    Registry record
    NCT04649242 · updated
  3. Efficacy of Nerve Blocks for Episodic Migraine

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT05734625 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Rochester, MN on ClinicalTrials.gov.

Ask about studies near Rochester

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Minnesota

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call